GlassScriptPhysician profile
Adam Scottaline
NPI 1992546105
$3,588.25
in general payments reported to CMS, 2019-2025
12 companies · $2,505 in 2025
The $2,505 reported for 2025 was more than what 92% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,083 · 2025: $2,505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,588.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,014.09 | 2024-2025 | Propel, Stealthstation S8 Platform |
| Integra Lifesciences Corporation | $892.24 | 2024-2025 | Integra, Acclarent Aera, Relieva Spinplus Nav |
| Inspire Medical Systems, INC. | $382.97 | 2024-2025 | Inspire |
| Ars Pharmaceuticals Operations, INC. | $235.47 | 2025 | Neffy |
| Hologic Sales and Service, LLC | $215.27 | 2025 | Coolseal Generator |
| Aroa Biosurgery Incorporated | $176.50 | 2025 | |
| Neurent Medical Limited | $170.74 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Acera Surgical, INC. | $126.61 | 2024 | Restrata Wound Matrix |
| Glaxosmithkline, LLC. | $125.16 | 2025 | Nucala |
| Optinose US, INC. | $125.00 | 2025 | |
| Stryker Corporation | $105.58 | 2025 | Scopis Ent |
| Regeneron Healthcare Solutions, INC. | $18.62 | 2025 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Scottaline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.